New Medical Products: New Drug Approved for Parkinson?s Disease
Published by Food and Drug Adminstration (FDA): Patient Safety July 31st, 2006 in Patient Safety, Regulatory AffairsFDA recently approved a new drug to treat Parkinson’s disease, called Azilect (rasagiline). Azilect is an MAO type-B inhibitor that blocks the breakdown of dopamine in the brain. Azilect was approved as a single therapy for treating early Parkinson…